Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|5|419-428

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.5, 2015-03, pp. : 419-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 895-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver transplantation arrests and reverses muscle wasting

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 3, 2015-03 ,pp. : 216-221

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of infliximab on oxidative stress in chronic inflammatory joint disease

By Túnez I.   Feijóo M.   Huerta G.   Montilla P.   Muñoz E.   Ruíz A.   Collantes E.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1259-1267

Informa Healthcare

Access to resources Recommend Favorite

Letter: infliximab therapy for patients with inflammatory bowel disease – some unanswered questions

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 9, 2015-11 ,pp. : 1133-1133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: infliximab therapy for patients with inflammatory bowel disease – some unanswered questions

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 9, 2015-11 ,pp. : 1133-1133

John Wiley & Sons Inc

Access to resources Recommend Favorite